7-Chloro-4-[(4-chlorophenyl)methyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-3-one

Catalog No. :
ACJOOE123
CAS No. :
1340932-45-7
Molecular Formula :
C16H13Cl2NO2
Molecular Weight :
322.19

IUPAC Name:7-chloro-4-(4-chlorobenzyl)-4,5-dihydrobenzo[f][1,4]oxazepin-3(2H)-one

7-Chloro-4-[(4-chlorophenyl)methyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-3-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$214.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Chloro-4-[(4-chlorophenyl)methyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-3-one
IUPAC Name7-chloro-4-(4-chlorobenzyl)-4,5-dihydrobenzo[f][1,4]oxazepin-3(2H)-one
MDL No.MFCD28042941
Molecular FormulaC16H13Cl2NO2
Molecular Weight322.19
SMILESO=C1COC2=CC=C(Cl)C=C2CN1CC3=CC=C(Cl)C=C3
InChI KeyDTKNAQLARUDQIN-UHFFFAOYSA-N
Synonym7-chloro-4-[(4-chlorophenyl)methyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-3-one;1,4-Benzoxazepin-3(2H)-one, 7-chloro-4-[(4-chlorophenyl)methyl]-4,5-dihydro-
CAS No.1340932-45-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJOOE123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJOOE123 route product structure diagram
    ACJOOE1231340932-45-7
Inquiry

2. ACJOOE123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJOOE123 route product structure diagram
    ACJOOE1231340932-45-7
Inquiry

Comments (0)